Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Psilocybin and Spiritual Practice

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: psilocybin
Behavioral: Intensity of support for spiritual practice
Behavioral: Number of sessions

First Posted Date: 2008-12-04

Last Posted Date: 2016-02-24

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 75

Registration Number: NCT00802282

Locations: 🇺🇸
Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients

Phase 2

Terminated

Conditions: Hypoglycemia
Critically Ill

Interventions: Drug: Glucagon-Like Peptide-1
Drug: Saline

First Posted Date: 2008-11-26

Last Posted Date: 2017-07-02

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 19

Registration Number: NCT00798590

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Hypoxia-inducible Factor-1 (HIF-1) Regulated Circulating Angiogenic Cells (CACs) Recruitment in Burn Wound Healing

Not Applicable

Terminated

Conditions: Wound Healing
Burns

Interventions: Other: Burn volunteers
Genetic: Healthy volunteers

First Posted Date: 2008-11-24

Last Posted Date: 2017-09-29

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 41

Registration Number: NCT00796627

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Partnership for Rapid Elimination of Trachoma

Phase 4

Completed

Conditions: Trachoma

Interventions: Drug: Azithromycin

First Posted Date: 2008-11-18

Last Posted Date: 2017-07-18

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 128

Registration Number: NCT00792922

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
UCSF Proctor Foundation, San Francisco, California, United States
🇬🇧
London School of Hygiene and Tropical Medicine, London, United Kingdom

The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic Patients

Phase 2

Terminated

Conditions: Diabetes Mellitus, Type 1

Interventions: Drug: Placebo
Drug: Pancreatic Polypeptide (PP)

First Posted Date: 2008-11-14

Last Posted Date: 2017-07-12

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 8

Registration Number: NCT00791076

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Use of Nitric Oxide Metabolites for Predicting Embryo Quality in In-Vitro Fertilization (IVF)

Not Applicable

Terminated

Conditions: Infertility

Interventions: Procedure: Transfer of embryos on day 3 or day 5 after fertilization.
Procedure: Day 5 transfer

First Posted Date: 2008-11-11

Last Posted Date: 2017-12-11

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 2

Registration Number: NCT00788619

Locations: 🇺🇸
Johns Hopkins Fertility Center, Lutherville, Maryland, United States

Improving Delivery of Mental Health Services for Patients With Drug Use and Other Behavioral and Emotional Problems

Not Applicable

Completed

Conditions: Study Focusing on Integrated Versus Non-integrated Psychiatric Care in
Diagnoses
Opioid-dependent and Methadone Treated Patients With Other Psychiatric

Interventions: Behavioral: Counseling compliance

First Posted Date: 2008-11-07

Last Posted Date: 2017-03-06

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 380

Registration Number: NCT00787735

Locations: 🇺🇸
Addiction Treatment Services, Baltimore, Maryland, United States

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Phase 3

Completed

Conditions: Intraventricular Hemorrhage

Interventions: Other: Normal saline
Drug: Alteplase

First Posted Date: 2008-11-02

Last Posted Date: 2018-12-05

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 500

Registration Number: NCT00784134

Locations: 🇺🇸
Springfield Neurological and Spine Institute, Springfield, Missouri, United States
🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸
University of Maryland, Baltimore, Maryland, United States

and more 78 locations

Evaluating the Effectiveness of a Community Exercise Program to Reduce the Risk of Metabolic Syndrome Among Black Americans

Phase 3

Completed

Conditions: Metabolic Syndrome

Interventions: Behavioral: Community-Based Exercise Program (C-FIT)
Behavioral: Self-Help Exercise Program (HOME)

First Posted Date: 2008-10-31

Last Posted Date: 2014-03-11

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 204

Registration Number: NCT00783445

Locations: 🇺🇸
Johns Hopkins Bayview Institute for Clinical Translational Research, Baltimore, Maryland, United States

Evaluating Weight Loss Programs for Obese People at Risk for Heart Disease (The POWER Study)

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Self-Directed Weight Loss Program
Behavioral: Call-Center Directed (CCD) Weight Loss Program
Behavioral: In-Person Directed (IPD) Weight Loss Program

First Posted Date: 2008-10-31

Last Posted Date: 2018-09-05

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 415

Registration Number: NCT00783315

Locations: 🇺🇸
ProHealth, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy